LENSAR, Inc.
LNSR • NASDAQ
LENSAR, Inc. is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Nicholas T. Curtis, with a market cap of $72.5M.
CEONicholas T. Curtis
Next Earnings
Upcoming earnings announcement for LENSAR, Inc.
Date
Thursday, May 7, 2026 (in 3 weeks)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
$0.49
Revenue Estimate
$13.4M
Earnings History
Past 12 earnings reports for LENSAR, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | Q4 2025 | -$0.12Est: -$0.10 | -20.0% | $16.0MEst: $20.3M | -21.1% |  10-K |
| Nov 6, 2025 | Q3 2025 | -$0.31Est: -$0.08 | -287.5% | $14.3MEst: $17.8M | -19.3% | 10-Q |
| Aug 7, 2025 | Q2 2025 | -$0.15Est: -$0.07 | -114.3% | $13.9MEst: $16.6M | -15.8% | 10-Q |
| May 8, 2025 | Q1 2025 | -$2.32Est: -$0.16 | -1350.0% | $14.2MEst: $13.4M | +5.7% | 10-Q |
| Feb 27, 2025 | Q4 2024 | -$1.61Est: -$0.18 | -794.4% | $16.7MEst: $15.0M | +11.9% | 10-K |
| Nov 7, 2024 | Q3 2024 | -$0.13Est: -$0.29 | +55.2% | $13.5MEst: $11.5M | +17.7% | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$0.46Est: -$0.29 | -58.6% | $12.6MEst: $12.2M | +4.0% | 10-Q |
| May 9, 2024 | Q1 2024 | -$0.19Est: -$0.28 | +32.1% | $10.6MEst: $10.6M | +0.4% | 10-Q |
| Mar 4, 2024 | Q4 2023 | -$0.35Est: -$0.22 | -59.1% | $12.1MEst: $12.0M | +0.9% | 10-K |
| Nov 9, 2023 | Q3 2023 | -$0.23Est: -$0.34 | +32.4% | $9.8MEst: $10.2M | -4.0% | — |
| Aug 9, 2023 | Q2 2023 | -$0.26Est: -$0.35 | +25.7% | $12.0MEst: $10.0M | +20.1% | — |
| May 15, 2023 | Q1 2023 | -$0.40Est: -$0.27 | -48.1% | $8.3MEst: $9.1M | -9.3% | — |